• Something wrong with this record ?

Therapeutic drug monitoring guided fluconazole therapy in a patient with cholangitis sepsis

J. Duricova, P. Jadrnickova, H. Brozmanova, I. Kacirova

. 2022 ; 19 (1) : 9-14. [pub] 20211108

Language English Country Great Britain

Document type Journal Article

Persistent link   https://www.medvik.cz/link/bmc22011578

Candida and other fungal species play an increasing role in nosocomial infections, including cholangitis and cholangiosepsis. Early diagnosis and prompt treatment are essential in successful patient outcomes. Fluconazole is an antifungal of choice in fluconazole-sensitive Candida infections. Little information is known about the fluconazole biliary excretion. Decreased tissue penetration may be one of the possible causes of treatment failure. Due to favorable pharmacokinetics, therapeutic drug monitoring of this antifungal has not been recommended routinely. In the presented case we report the successful therapeutic drug monitoring-guided fluconazole treatment in a patient with cholangitis and cholangiosepsis caused by fluconazole-sensitive Candida spp.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22011578
003      
CZ-PrNML
005      
20220506130442.0
007      
ta
008      
220425s2022 xxk f 000 0|eng||
009      
AR
024    7_
$a 10.2217/pme-2021-0010 $2 doi
035    __
$a (PubMed)34747184
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxk
100    1_
$a Duricova, Jana $u Department of Clinical Pharmacology, Department of Laboratory Medicine, University Hospital Ostrava, Ostrava, Czech Republic $u Department of Clinical Pharmacology, Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic $1 https://orcid.org/0000000241584896
245    10
$a Therapeutic drug monitoring guided fluconazole therapy in a patient with cholangitis sepsis / $c J. Duricova, P. Jadrnickova, H. Brozmanova, I. Kacirova
520    9_
$a Candida and other fungal species play an increasing role in nosocomial infections, including cholangitis and cholangiosepsis. Early diagnosis and prompt treatment are essential in successful patient outcomes. Fluconazole is an antifungal of choice in fluconazole-sensitive Candida infections. Little information is known about the fluconazole biliary excretion. Decreased tissue penetration may be one of the possible causes of treatment failure. Due to favorable pharmacokinetics, therapeutic drug monitoring of this antifungal has not been recommended routinely. In the presented case we report the successful therapeutic drug monitoring-guided fluconazole treatment in a patient with cholangitis and cholangiosepsis caused by fluconazole-sensitive Candida spp.
650    _2
$a antifungální látky $x terapeutické užití $7 D000935
650    12
$a cholangitida $x farmakoterapie $7 D002761
650    _2
$a monitorování léčiv $7 D016903
650    _2
$a flukonazol $x terapeutické užití $7 D015725
650    _2
$a lidé $7 D006801
650    _2
$a mikrobiální testy citlivosti $7 D008826
650    12
$a sepse $x farmakoterapie $7 D018805
655    _2
$a časopisecké články $7 D016428
700    1_
$a Jadrnickova, Pavla $u Department of Internal Medicine, University Hospital Ostrava, Ostrava, Czech Republic
700    1_
$a Brozmanova, Hana $u Department of Clinical Pharmacology, Department of Laboratory Medicine, University Hospital Ostrava, Ostrava, Czech Republic $u Department of Clinical Pharmacology, Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic $1 https://orcid.org/0000000205863927
700    1_
$a Kacirova, Ivana $u Department of Clinical Pharmacology, Department of Laboratory Medicine, University Hospital Ostrava, Ostrava, Czech Republic $u Department of Clinical Pharmacology, Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic $1 https://orcid.org/000000016618754X $7 xx0081201
773    0_
$w MED00008686 $t Personalized medicine $x 1744-828X $g Roč. 19, č. 1 (2022), s. 9-14
856    41
$u https://pubmed.ncbi.nlm.nih.gov/34747184 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20220425 $b ABA008
991    __
$a 20220506130434 $b ABA008
999    __
$a ok $b bmc $g 1789270 $s 1162776
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2022 $b 19 $c 1 $d 9-14 $e 20211108 $i 1744-828X $m Personalized medicine $n Per Med $x MED00008686
LZP    __
$a Pubmed-20220425

Find record

Citation metrics

Archiving options